Symbol="EGRX"
AssetType="Common Stock"
Name="Eagle Pharmaceuticals Inc"
Description="Eagle Pharmaceuticals, Inc., a biotechnology pharmaceutical company, focuses on developing and marketing injectable products primarily in the areas of metabolic critical care and oncology in the United States. The company is headquartered in Woodcliff Lake, New Jersey."
CIK="827871"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="50 TICE BOULEVARD, SUITE 315, WOODCLIFF LAKE, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="276750000"
EBITDA="69080000"
PERatio="None"
PEGRatio="0.91"
BookValue="18.56"
DividendPerShare="0"
DividendYield="0"
EPS="-0.27"
RevenuePerShareTTM="20.51"
ProfitMargin="-0.01"
OperatingMarginTTM="0.196"
ReturnOnAssetsTTM="0.0892"
ReturnOnEquityTTM="-0.0116"
RevenueTTM="267041000"
GrossProfitTTM="221674000"
DilutedEPSTTM="-0.27"
QuarterlyEarningsGrowthYOY="-0.871"
QuarterlyRevenueGrowthYOY="-0.428"
AnalystTargetPrice="26"
TrailingPE="-"
ForwardPE="11.34"
PriceToSalesRatioTTM="1.293"
PriceToBookRatio="1.724"
EVToRevenue="1.506"
EVToEBITDA="7.57"
Beta="0.871"
num_52WeekHigh="43.59"
num_52WeekLow="17.09"
num_50DayMovingAverage="19.52"
num_200DayMovingAverage="27.49"
SharesOutstanding="13091300"
DividendDate="None"
ExDividendDate="None"
symbol="EGRX"
open="21.19"
high="21.77"
low="20.98"
price="21.17"
volume="286927.00"
latest_trading_day="2023-08-03"
previous_close="21.10"
change="0.07"
change_percent="0.3318%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="96"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="4"
Volume_recent_avg="192034"
Change_recent_avg="-0.08"
Delta_recent_avg="1.07"
Variance_recent_avg="0.54"
Change_ratio_recent_avg="-0.41"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="4"
Aroon_momentum_negative="96"
image_negative_thumbnail_id_1="1103"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0136.jpeg"
image_negative_thumbnail_id_2="487"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0118.jpeg"
image_neutral_thumbnail_id_1="528"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0071.jpeg"
image_neutral_thumbnail_id_2="568"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_positive_thumbnail_id_1="951"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0113.jpeg"
image_positive_thumbnail_id_2="607"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0101.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1167"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
